RxDoctor Payments Data

Hanaah Fannin, PA

Physician Assistant · Carlsbad, CANPI 1326680240

Payments from drug & device makers

$960in general payments, 2019–2025

Across 44 payments — averaging $21.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$314
  • Novo Nordisk$90
  • Gilead$60
  • Lilly USA, LLC$53
  • Pfizer$52
  • Sanofi$50
  • plus $342 from 12 others

What the payments were for

  • Food & beverage$960100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$960 in reported general payments places this provider in the 70th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$31,675
Medicare patients
63
Services billed
510

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide89$120,461
MounjaroTirzepatide34$42,760
Repatha SureclickEvolocumab35$23,760
EliquisApixaban15$17,258
LinzessLinaclotide14$6,928
Wixela InhubFluticasone Propion/Salmeterol28$2,684
Rosuvastatin Calcium102$1,762
Atorvastatin Calcium151$1,556
Levothyroxine Sodium88$1,287
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$1,118
Losartan Potassium104$1,075
Gabapentin47$775
Albuterol Sulfate HfaAlbuterol Sulfate28$664
Escitalopram Oxalate57$562
Estradiol20$540

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$90$120,46189 claims
Lilly USA, LLCMounjaro$53$42,76034 claims
PfizerEliquis$52$17,25815 claims
AbbVieLinzess$314$6,92814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Carlsbad

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →